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a  b  s  t  r  a  c  t
In many  settings,  interventions  targeting  female  sex workers  (FSWs)  could  signiﬁcantly  reduce  the  overall
transmission  of HIV.  To  understand  the  role  HIV  pre-exposure  prophylaxis  (PrEP)  could  play  in controlling
HIV  transmission  amongst  FSWs,  it is  important  to  understand  how  its impact  compares  with scaling-up
condom  use—one  of  the  proven  HIV  prevention  strategies  for FSWs.  It  is important  to remember  that
condoms  also  have  other beneﬁts  such  as  reducing  the  incidence  of  sexually  transmitted  infections  and
preventing  pregnancy.  A  dynamic  deterministic  model  of  HIV  transmission  amongst  FSWs,  their  clients
and  other  male  partners  (termed  ‘pimps’)  was used  to  compare  the  protection  provided  by PrEP  for
HIV-negative  FSWs  with  FSWs  increasing  their  condom  use  with clients  and/or  pimps.  For different  HIV
prevalence  scenarios,  levels  of pimp  interaction,  and baseline  condom  use,  we estimated  the  coverage of
PrEP  that  gives  the  same  reduction  in endemic  FSW  HIV prevalence  or HIV  infections  averted  as  different
increases  in  condom  use.  To  achieve  the  same  impact  on FSW  HIV prevalence  as  increasing  condom  use  by
1%,  the  coverage  of  PrEP  has  to increase  by >2%.  The  relative  impact  of PrEP  increases  for scenarios  where
pimps  contribute  to HIV  transmission,  but not  greatly,  and  decreases  with  higher  baseline  condom  use.
In terms  of  HIV  infections  averted  over  10 years,  the  relative  impact  of  PrEP  compared  to  condoms  was
reduced,  with  a  >3%  increase  in  PrEP coverage  achieving  the same  impact  as  a 1%  increase  in condom  use.
Condom  promotion  interventions  should  remain  the  mainstay  HIV prevention  strategy  for FSWs,  with
PrEP  only  being  implemented  once  condom  interventions  have  been  maximised  or to ﬁll prevention  gaps
where  condoms  cannot  be used.
© 2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Oral pre-exposure prophylaxis (PrEP), which involves the use of
antiretroviral agents by HIV uninfected individuals to reduce the
risk of acquiring HIV, is a new HIV prevention measure being con-
sidered in affected regions (Baeten et al., 2013). There have been
mixed ﬁndings from PrEP trials mostly due to different levels of
adherence among targeted population groups (Amico and Stirratt,
2014), with two trials amongst African women showing no efﬁ-
cacy (Amico and Stirratt, 2014; Van Damme  et al., 2012), and other
trials demonstrating efﬁcacy between 39% and 73% among hetero-
sexuals (Baeten et al., 2012; Thigpen et al., 2012), 44–86% efﬁcacy
among men  who have sex with men  (Grant et al., 2010; Molina et al.,
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2015; McCormack, 2015) and 49% efﬁcacy among injecting drug
users (Choopanya et al., 2013). In these studies, higher PrEP efﬁ-
cacy was achieved amongst individuals with detectable drug levels
(Amico and Stirratt, 2014). Although the ﬁndings (Baeten et al.,
2012; Thigpen et al., 2012; Grant et al., 2010; Abdool Karim et al.,
2010) clearly show the utility of PrEP in reducing the risk of acquir-
ing HIV when used with high adherence (Grant et al., 2014), further
studies are required to help design the best strategies of adminis-
tration, and to determine cost-effectiveness in different risk groups
and settings (Baeten et al., 2013; Alistar et al., 2014; Hellinger, 2013;
Okwundu et al., 2012).
FSWs are a critical group for preventive interventions (Alary
et al., 2013) because they contribute disproportionally to HIV trans-
mission (Alary and Lowndes, 2004; Boily et al., 2002; Vickerman
et al., 2010; Steen et al., 2014). PrEP use could be highly effec-
tive in this group because of their high HIV acquisition risk. For
making decisions about prioritising interventions it is important
to understand how the impact of PrEP compares with scaling up
other prevention strategies such as condom use promotion, which
http://dx.doi.org/10.1016/j.epidem.2015.10.002
1755-4365/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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can be increased to high levels amongst FSWs and clients (Behanzin
et al., 2013; Pickles et al., 2013; Tran et al., 2006; Foss et al., 2007).
Also, while both PrEP and condoms reduce the risk of HIV acquisi-
tion amongst susceptible FSWs, condoms also reduce the chance of
transmission from infected FSWs. However, condoms are not used
in all sexual partnerships, such as long-term partnerships where
intimacy is important or partnerships where there is an imbalanced
power relationship, and so sometimes can have limited effective-
ness (Foss et al., 2007; Watts et al., 2010; Moreno et al., 2014). For
FSWs, this includes relationships with men  involved in the sex trade
(Lowndes et al., 2000) who may  have a higher HIV prevalence than
the clients of FSWs and could be important for HIV transmission
(Watts et al., 2010; Lowndes et al., 2000). We  denote these men
‘pimps’. PrEP could be important for protecting FSWs from these
men.
The likely relative population effectiveness or impact of prod-
ucts can sometimes be simply compared by assessing their efﬁcacy
and likely consistency or coverage of use (Heise et al., 2011; Foss
et al., 2003), but if one product only protects against transmission
in one direction or the products are used by different popula-
tion groups then it is hard to make product comparisons without
assessing the population impact of both interventions (Foss et al.,
2009). In this paper, we use a purposely simple model to get insights
into the impact of targeting PrEP to FSWs in scenarios where pimps
either do or do not contribute to HIV transmission. We  compare the
impact of PrEP to that of condoms to determine what PrEP cover-
age is equivalent to speciﬁc increases in the consistency of condom
use. We  consider the impact of PrEP and condoms within the FSW,
client and pimp population groups with the main aim of the study
being to use different quantiﬁable impact measures to compare the
relative impact of PrEP to condoms. In so doing, we want to give
insights into PrEP’s relative importance for preventing HIV trans-
mission amongst FSWs and guidance into when it may  be more
beneﬁcial to introduce PrEP, or otherwise prioritise the scale-up of
condom use amongst FSWs.
2. Methods
We  use a mathematical model describing HIV transmission
between FSWs, their clients and pimps to estimate the relative
impact of PrEP and condom use by FSWs. The model structure,
formulation details and analyses are described below.
2.1. Model formulation
The model stratiﬁes the population into three classes, with y0, y1
and y2 denoting the HIV prevalence amongst female sex workers
(FSWs), their clients, and pimps, respectively. The corresponding
population sizes are n0, n1 and n2. Individuals are infected at rates
0 = ˇ0c0, 1 = ˇ1c1, 2 = ˇ1c2 and 3 = ˇ0c3 which are forces of
infection of sex worker clients by FSWs, FSWs by clients, FSWs
by pimps and pimps by FSWs, respectively. Here, ˇ0 and ˇ1 are
probabilities of HIV transmission per sex act from infected females
to males and vice-versa, respectively. The parameters c0, c1, c2
and c3 denote number of sex acts per month by each client with
FSWs, by each FSW with clients, by each FSW with pimps and
by each pimp with FSWs, respectively. For partnerships between
pimps and FSWs, we deﬁne c2 = c∗2m and c3 = c∗3m where c∗2 and
c∗3 are the number of pimp or FSW partners per month, respec-
tively, and m is the number of sex acts between each pimp and FSW
per month. To balance the total number of partnerships formed
between clients and FSWs or pimps and FSWs we ensure that
c0n0 = c1n1 and c∗2n1 = c∗3n2.
The rates of leaving being a FSW, client or pimp are given by
˛0, ˛1 and ˛2 and the HIV-related death rate is denoted by . For
Fig. 1. HIV model schematic outlining the sexual behaviour structure. The arrows
connecting compartments denote forces of HIV infection at rates 0, 1, 2 and 3 for
clients by FSWs, FSWs by clients, FSWs by pimps and pimps by FSWs, respectively.
The arrows out of the compartments denote rates of leaving being a FSW, client,
pimp and HIV-related death given by ˛0, ˛1, ˛2 and , respectively.
mathematical simplicity and tractability, the model does not incor-
porate anti-retroviral treatment or the initial acute phase of HIV.
The model equations are included in the Supplementary methods
and model schematic is in Fig. 1.
Two  versions of the model were developed with and without
the pimp sub-group included. Within both models, condom and
PrEP use are assumed to result in a reduced force of infection by
factors (1 − ef1) , (1  − ef2) and
(
1 − 
)
, where e denotes efﬁcacy of
condom use, f1 is the average consistency of condom use between
clients and FSWs, f2 is the consistency of condom use between
pimps and FSWs (only relevant for model including pimps),  is
the efﬁcacy of PrEP and  is the proportion of HIV-negative FSWs
that use PrEP adherently. It is assumed that both interventions are
FSW-targeted, such that PrEP is only used by HIV-uninfected FSWs,
and only reduces HIV transmission to these FSWs, whereas con-
doms are used by all FSWs at an average consistency dependent on
whether the sexual partner is a pimp or a client and so also partially
protects uninfected clients and pimps.
2.2. Model parameterization
The model is parameterized using data from different sources as
in Table 1 and in Supplementary material. Point values are used for
most parameters except for the probabilities of HIV transmission,
which are varied to give different HIV prevalences or basic repro-
ductive numbers, and the consistency of condom use and coverage
of PrEP which are varied to make comparisons between differ-
ent intervention scenarios. Of particular note amongst the other
parameters are the number and frequency of pimp sexual part-
nerships and acts with FSWs, which have considerable uncertainty
and so four scenarios were considered (Table 1). These pimp sce-
narios are: S1: pimps have sex with 8 FSWs per month and FSWs
have 2 pimps per month with 2 sex acts with each per month; S2:
pimps have sex with 4 FSWs per month and FSWs have 2 pimps
per month with 2 sex acts with each per month; S3: pimps have
sex with 4 FSWs per month and FSWs have 1 pimps per month
with 1 sex acts with each per month; and S4: pimps have sex with
1 FSWs per month and FSWs have 1 pimps per month with 1 sex
acts with each per month. For these scenarios, the consistency of
condom use between pimps and FSWs is assumed to be a third of
the consistency of use between clients and FSWs (Lowndes et al.,
2002). Lastly, all baseline impact comparisons assume a condom
efﬁcacy of 85% (Pinkerton et al., 1998; Pinkerton and Abramson,
1997; Davis and Weller, 1999) and a PrEP efﬁcacy of 70% (Baeten
et al., 2012; Thigpen et al., 2012; Grant et al., 2010). A sensitivity
analysis considered the effect of varying these and other parameter
assumptions.
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Table 1
Model parameter values.
Parameter deﬁnition Symbol Baseline value or range
[values used in sensitivity
analysis]
References and notes
Population sizes
Total client population size n1 c0n0/c1 Calculated to balance the number of commercial sex acts had
by  clients and FSW
Total  FSW population n0 1000 Assumed FSW population size
Total pimp population n2 c0n0/c0 Calculated to balance the number of pimp sex acts had by FSW
and pimps
HIV  transmission and epidemiological
parameters
Probability of HIV transmission from females
to  males per sex act
ˇ0 0.0001–0.011 Boily et al. (2009). Varied to ﬁt different HIV prevalence
scenarios in the analysis
Probability of HIV transmission from males
to  females per sex act
ˇ1 =ˇ0
HIV death rate per year  0.125 Morgan et al. (2000), WHO  (2013), Alcabes et al. (1994)
Efﬁcacy of condoms e 85% [60,95%] Lowndes et al. (2002), Pinkerton et al. (1998), Pinkerton and
Abramson (1997), Hughes et al. (2012), Weller and
Davis-Beaty (2002). We chose 85% as baseline value but varied
it in sensitivity analysis
Efﬁcacy of PrEP  70% [45,95%] Baeten et al. (2012), Thigpen et al. (2012). Estimates vary but
we  choose an efﬁcacy of 70%
FSW  behaviour parameters
Rate at which FSWs have commercial sex
with clients per month
c1 50 [25,100] Vickerman et al. (2010), Ramesh et al. (2008),  FMOH (2007).
Estimates vary, but chose 50 partners/month
Rate  at which FSWs have sex acts with pimps
per month–calculated as a product of the
number of pimps have sex with per month(
c∗2
)
and number of sex acts between each
FSW and pimp per month (m)
c∗2 × m S1 and S2: c∗2 = 2 and m = 2
S3 and S4: c∗2 = 1 and m = 1
4 Scenarios considered based on previous modelling of HIV
transmission amongst FSWs and pimps (Watts et al., 2010)
Consistency of condom use between clients
and FSWs
f1 0–100% variable Considered different scenarios to compare impact with PrEP
Consistency of condom use between pimps
and FSWs
f2 1/3f1 [0.15f1, 0.6f1] Condom use with pimps is assumed to be 1/3 of level of
condom use with clients (Foss et al., 2009)–0.15 and 0.6
considered in sensitivity analysis
Proportion of FSW that use PrEP  0–100% variable Considered different scenarios to compare impact with
condoms
Rate  of leaving being a FSW per year ˛0 0.25 [0.125, 0.5] Varies widely (Watts et al., 2010; Ramesh et al., 2008; FMoH,
2010; Jadhav et al., 2013). We use 0.25 per year as baseline
value and vary in our sensitivity analysis
Client behaviour parameters
Rate at which clients have commercial sex
with FSW per month
c0 5 [2.5, 10] Varies widely (Vickerman et al., 2010; Moreno et al., 2014;
Subramanian et al., 2008; Shaw et al., 2011). We use 5
partners/month as baseline value and vary in sensitivity
analysis
Rate  of leaving being a client per year ˛1 0.16 [0.08, 0.32] Varies (Moreno et al., 2014; Shaw et al., 2011; Wilson et al.,
1989). We use 0.16 as our baseline value and vary it in
sensitivity analysis
Pimp behaviour parameters
Rate at which pimps have sex with FSW per
month–calculated as a product of the
number of FSWs have sex with per month(
c∗3
)
and number of sex acts between each
FSW and pimp per month (m)
c∗3 × m S1: c∗3 = 8 and m = 2
S2: c∗3 = 4 and m = 2
S3: c∗3 = 4 and m = 1
S4: c∗3 = 1 and m = 1
Four scenarios considered based on previous modelling of HIV
transmission amongst FSWs and pimps (Watts et al., 2010).
Rate  of leaving being a pimp per year ˛2 S1–S4: 0.1 Based on Watts et al. (2010)
2.3. Summary of model analysis
Model analyses were carried out for the scenario without pimps
followed by the scenario with pimps, and made comparisons of
the relative impact of condoms and PrEP using analytical and
numerical approaches. Using the model without pimps, we began
by comparing the impact on the number of secondary infections
over the infectious period (R0 amongst the FSWs and clients)
and endemic FSW HIV prevalence of different consistencies of
condom use and coverage levels of PrEP when each intervention
is introduced in to a population at endemic prevalence. With and
without pimps, we then assessed the relative impact of PrEP by
estimating the average increase in the consistency of condom use
that gives the same impact as a unit increase in PrEP coverage
(further details in Supplementary materials). For comparison,
impact was either assessed in terms of reductions in the endemic
FSW HIV prevalence or number of HIV infections averted amongst
all modelled groups over 10 years. This analysis was undertaken
for different endemic FSW HIV prevalences and baseline levels of
condom use to see their effect on the model projections.
3. Results
3.1. Analysis of the model without pimps
3.1.1. Performance of PrEP with no condom use at baseline
Supplementary Fig. S1 shows a roughly linear relationship exists
between the coverage of PrEP () and consistency of condom use
(f1) that achieves the same impact in reducing the basic reproduc-
tive number (R0) for the transmission of HIV between FSWs and
clients. Note that R0 estimated here only quantiﬁes transmission
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Fig. 2. Shows the relationship between the coverage of PrEP use () and consistency of condom use (f1) required to achieve the same impact in reducing FSW HIV  prevalence
at  endemic equilibrium while assuming no condom or PrEP use at baseline. We vary the transmission probabilities to give different R0 values of 1.2, 3 and 10 which correspond
to  endemic HIV prevalence of 21%, 69% and 90%, respectively, using other parameters values given in Table 1. Consistency of condom use and coverage of PrEP use are varied
in  the range 0–100%.
between FSWs and clients, and does not take into transmission in
the wider population. This relationship is independent of R0, and
suggests that approximately twice the coverage of PrEP is required
to achieve the same impact as a speciﬁc consistency of condom use.
Fig. 2 illustrates that a similar linear relationship exists between
the coverage of PrEP () and consistency of condom use (f1) when
we consider the impact on decreasing FSW HIV prevalence (pro-
jections against time are in the Supplementary material), but the
relationship is now dependent on R0, with the factor difference
decreasing for settings with greater HIV transmission. This suggests
that the relative impact of PrEP compared to condoms becomes
greater for higher levels of HIV transmission. For example, for FSW
and client HIV epidemics with a basic reproductive number of 1.2,
3 and 10 (FSW HIV prevalence 21%, 69% and 90%, respectively), the
impact of 100% coverage of PrEP use in reducing FSW HIV preva-
lence is equivalent to the impact of condom use increasing from 0
to 47, 58 or 70% consistency, respectively.
For a range of epidemic scenarios, Fig. 3(a) presents the rela-
tive impact of PrEP (non-pimp scenario) compared to condoms for
decreasing FSW HIV prevalence, as given by the average relative
increase in consistency of condom use (f1) required to achieve the
same impact on FSW HIV prevalence as a unit increase in PrEP cov-
erage () amongst HIV negative FSWs. Fig. 3(a) (non-pimp model)
shows that although the relative impact of PrEP increases as HIV
prevalence increases, a unit increase in the consistency of condom
use generally results in approximately double the impact of a unit
increase in PrEP coverage except at very high FSW HIV prevalence
(>65%).
When impact is assessed in terms of HIV infections averted (over
10 years) instead of decreases in FSW HIV prevalence, Fig. 3(b)
shows that the relative impact of PrEP (non-pimp scenario) (aver-
age relative increase in consistency of condom use (f1) required
to achieve the same impact as a unit increase in PrEP coverage
()) is generally lower than for the impact on FSW HIV prevalence
and now decreases as FSW HIV prevalence increases, although
improves slightly over longer time frames (Supplementary Fig. S3).
For example, at low FSW prevalence (10%), the consistency of con-
dom use needs to increase by 0.4 unit to achieve the same impact
over 10 years as a unit increase in PrEP coverage, whereas at high
HIV prevalence (65%) this ratio reduces to about 0.25.
3.1.2. Performance of PrEP with varying condom use at baseline
Previous projections assumed no condom or PrEP use at base-
line. However, condoms are widely used by FSWs and so PrEP will
likely be introduced in settings with a pre-existing level of con-
dom use. Fig. 4 presents the average increase in condom use (f1)
required to achieve the same impact as a unit increase in PrEP cov-
erage () on reducing endemic FSW HIV prevalence or averting
HIV infections (over 10 years) for different baseline levels of con-
dom use and FSW HIV prevalence. For both impact measures, the
projections suggest that the relative impact of PrEP compared to
condoms diminishes at higher baseline levels of condom use. For
Fig. 3. The relative impact of PrEP compared to condoms for decreasing the endemic FSW HIV prevalence (a) or averting HIV infections (b) after 10 years for different baseline
FSW  HIV prevalences, with no condom or PrEP use at baseline. The relative impact of PrEP is deﬁned as the average increase in condom consistency that is required to have
the  same impact in decreasing FSW HIV prevalence or averting HIV infections as a unit increase in coverage of PrEP amongst HIV negative FSWs. Each ﬁgure considers the
results  for the model with no pimps and the model with pimps for four different pimp scenarios described in Section 2.
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Fig. 4. Relative impact of PrEP (average increase in condom consistency required to have the same impact as a unit increase in coverage of PrEP amongst HIV negative FSWs)
for  different baseline levels of condom use and FSW HIV prevalence, for scenario without pimps. Impact is either assessed in terms of decreases in FSW HIV prevalence (a)
or  number of HIV infections averted over 10 years (b). These were estimated using parameter values in Table 1.
example, in terms of decreasing HIV prevalence in FSWs, condom
consistency would only have to increase by 0.3% or 0.15% to match
the impact of a unit increase in PrEP coverage at a baseline condom
use of 40% or 80%, respectively. As before, PrEP seems less effective
at averting HIV infections than reducing FSW HIV prevalence and
this becomes more pronounced at higher HIV prevalence.
3.2. Analysis of the model with pimps
When the effect of pimps is included into the model, then Fig. 3
shows that the relative impact of PrEP compared to condoms, either
in terms of impact on FSW HIV prevalence or HIV infections averted,
can increase noticeably but only when pimps play an important
role in HIV transmission (i.e. have more FSW partners and sex acts
per month as in Scenarios 1 and 2—Supplementary Figs. S5–S8),
with the effect on FSW HIV prevalence being more pronounced.
This is also the case for different baseline levels of condom use.
Interestingly, PrEP seems to result in the same reduction in FSW
HIV prevalence and percentage of HIV infections averted (Supple-
mentary Fig. S4) irrespective of whether pimps contribute to HIV
transmission or not, whereas the impact of condoms reduces as
pimps contribute more to transmission. This is because condoms
do not protect the FSWs from pimps, whereas PrEP protects the
FSW from both their clients and pimps.
3.3. Sensitivity analysis
We  carried out a univariate sensitivity analysis to investigate
the effect of altering different model parameters on the relative
impact of PrEP compared to condoms for the scenario with 40% HIV
prevalence (FMoH, 2007) and 60% condom use at baseline. Only the
scenario with pimps (S1) was considered and the parameter varia-
tions considered are shown in Table 1 and Fig. 5. For each parameter
change, the model was reﬁt to the baseline 40% HIV prevalence.
The results (Fig. 5) suggest that changes in number of clients per
FSW or vice versa, overall leaving rates, and level of condom use
between FSWs and pimps will only affect the relative impact of
PrEP by less than 25%. This effect is lessened for the model with-
out pimps (Supplementary Fig. S9). However, uncertainty in the
efﬁcacy of condoms or PrEP can substantially affect the projected
relative impact of PrEP by up to a half if the efﬁcacy of condoms is
60% instead of 85% or the efﬁcacy of PrEP is 45% or 95% instead of
70% (depending on the adherence patterns of FSWs).
4. Discussion
Mathematical modelling was  used to compare the HIV impact of
PrEP and condom use among FSWs and clients. The model analyses
suggest that increasing PrEP use amongst FSWs is unlikely to result
in the same population level impact as increasing condom use. To
achieve the same decrease in FSW HIV prevalence, the increase in
PrEP coverage has to be roughly double the overall increase in con-
sistency of condom use if there is no PrEP or condom use at baseline,
and this becomes much greater if there is moderate to high condom
use at baseline (over four times if baseline condom use is over 50%)
or impact is assessed in terms of HIV infections averted (roughly
three times if no condom use at baseline and over ﬁve times if
50% condom use at baseline). Since condom use between FSWs
and their clients can be increased to high levels (Behanzin et al.,
2013; Foss et al., 2007; Lowndes et al., 2010; Rojanapithayakorn
and Hanenberg, 1996), these results highlight that in pursuing a
combination of HIV prevention programmes, intervention efforts
should prioritise maximising condom use before introducing PrEP
because greater population level impact is likely to be achieved. It
is also crucial that funds should not be channelled away from exist-
ing condom use interventions to fund PrEP strategies because any
reduction in condom use is likely to offset the beneﬁcial impact of
PrEP (Foss et al., 2003).
A possible important use for PrEP is protecting FSWs against HIV
transmission from ‘other’ male sexual partners that they have dif-
ﬁculty using condoms with. These male partners (termed ‘pimps’
in our model) could include boyfriends of FSWs or other individ-
uals involved in the sex industry (Watts et al., 2010; Lowndes et al.,
2000). When the model considered the importance of PrEP for sce-
narios where these ‘other’ male sexual partners play an important
role in transmitting HIV, the modelling suggested the importance
of PrEP is heightened because it affords FSWs protection in all their
sexual partnerships, whereas condoms do not. However, the effect
was not great, with a 1% increase in condom use between clients and
FSWs being equivalent to at least a 1.5% increase in PrEP coverage
except at very high FSW HIV prevalences (>80%). The importance
of FSW’s ‘other’ male sexual partners for driving HIV transmission
amongst FSW populations in different settings is poorly under-
stood, with just a few settings documenting their behaviour and
HIV transmission risk (Watts et al., 2010). Further work is needed
to characterise their importance for HIV transmission before accu-
rate predictions can be made of the degree to which these other
male partners could increase the importance of PrEP.
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Fig. 5. Sensitivity analysis on how the relative impact of PrEP changes for speciﬁc changes in model parameters. The relative impact of PrEP is deﬁned as the average increase
in  condom consistency that is required to have the same impact in either decreasing FSW HIV prevalence (a) or averting HIV infections over 10 years (b) as a unit increase in
coverage of PrEP amongst HIV negative FSWs. All projections are compared against a baseline impact scenario (shown as black dashed line) that assumes 40% HIV prevalence
amongst FSWs, 60% condom use between FSWs and clients and incorporates pimp scenario S1 (pimps have sex with 8 FSWs per month and FSWs have 2 pimps per month
with  2 sex acts with each per month). The parameter value variations considered are shown in the ﬁgure with the baseline values being: number of clients per FSW c1 = 50
per  month; number of FSWs per client c2 = 5 per month; yearly leaving rates for FSWs (˛0), clients (˛1), pimps (˛2) being 0.25, 0.16 and 0.1, respectively; condom efﬁcacy
e  = 85%; PrEP efﬁcacy  = 70%; and factor difference in condom consistency between pimps and FSWs compared to between clients and FSWs f2 = 33%.
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Several factors contribute to condoms having a greater impact
than PrEP. First, we assume that condoms have a greater efﬁcacy
per sex act than PrEP. Studies have estimated that PrEP efﬁcacy
amongst high adherers (with detectable drug in the blood) could
be as high as 90% (Grant et al., 2010; Baeten et al., 2012), compara-
ble to the effectiveness of condoms when used correctly (80–95%)
(Pinkerton et al., 1998; Davis and Weller, 1999). The lower esti-
mate (70%) used here reﬂects adherence levels seen in trials. It is
unknown how high PrEP adherence will be amongst FSWs, with
our sensitivity analysis emphasising this could have a large effect
on our projections. Demonstration projects are currently under-
way in various settings to assess the degree to which FSWs may
use and adhere to PrEP (WHO, 2015). Second, condoms offer two-
way protection, of clients as well as FSWs, whereas PrEP protects
only the FSWs taking it, with our modelling showing this is the
main cause for the higher overall impact achieved with condoms.
Although PrEP could be given to clients, this is unlikely in prac-
tise due to the difﬁculty in reaching this group with interventions.
Lastly, condoms are used by all FSWs whereas PrEP is only used
by those who are HIV negative. This makes direct comparisons
between consistency of condom use and PrEP coverage difﬁcult,
particularly for high HIV prevalence settings. When the coverage of
PrEP is adjusted to reﬂect its average coverage of use over all FSWs
then a unit increase in PrEP coverage can become more ‘effective’
than a unit increase in condom use at high HIV prevalence. How-
ever, the costs of each intervention are likely to be very different
(Creese et al., 2002; Vassall et al., 2014; Mitchell et al., 2015), with
the restriction of PrEP to HIV-negative FSWs limiting its potential
coverage and impact.
While all of our analyses suggested that condom use would have
greater impact than PrEP, the magnitude of the difference var-
ied considerably depending on the impact measure used, with a
greater difference occurring when impact was measured in terms
of infections averted rather than reduction in prevalence. This
increased difference in impact for infections averted is due to the
inclusion of HIV infections averted amongst clients which PrEP
achieves indirectly but condoms achieve directly, whereas PrEP has
a direct impact on reducing FSW HIV prevalence as do condoms, but
condoms also achieve added indirect impact through protecting
clients. Although prevalence is easier to measure in epidemiolog-
ical studies and needs to be reduced to low levels to ultimately
control an HIV epidemic, infections averted gives a better indica-
tion of intervention impact and cost-effectiveness, as prevalence
is also affected by other factors such as population turnover and
factors inﬂuencing survival.
Our model considered an average consistency of condom use
by all FSWs with their commercial clients. The reason we  did not
consider a coverage of condom use is because most FSWs use con-
doms to some degree. Despite this, it has been documented that
some FSWs ﬁnd it more difﬁcult to use condoms irrespective of how
well condoms are promoted and distributed (Reza-Paul et al., 2008;
Ramesh et al., 2010; Gangopadhyay et al., 2005; Kilmarx et al., 1999;
Bui et al., 2013; Bharat et al., 2013). If PrEP could be targeted to these
FSWs then it could be an important adjunct to existing interven-
tions for further decreasing HIV transmission. Ongoing PrEP studies
are considering the impact of such selective targeting (Eisingerich
et al., 2012; Ye et al., 2014).
Our modelling analysis had a number of other limitations, partly
due to the simplifying assumptions made to enable general com-
parisons of the impact of the two intervention strategies. First, the
model did not include different stages of HIV infection (with vary-
ing infectiousness), or anti-retroviral treatment, which has become
a cornerstone of HIV prevention programmes. While each of these
is important for estimating the impact of interventions, they are
not expected to have a large effect on the comparison of impact
between PrEP and condom use made in this paper. Second, the
model did not include behavioural heterogeneity amongst FSWs,
which could affect intervention impact. This could further reduce
the impact of PrEP because it only protects HIV negative FSWs
which are likely to be lower risk. Third, the development of resis-
tant strains following PrEP use was  not considered which could
also compromise the effectiveness of PrEP (Dimitrov et al., 2013).
Lastly, we only compared the relative impact of these interventions,
whereas in reality decisions on whether to scale up an intervention
should also consider the cost-effectiveness of each strategy (Alistar
et al., 2014; Walensky et al., 2012; Hallett et al., 2011; Nichols et al.,
2014; Kessler et al., 2014).
In conclusion, our modelling analyses emphasise that PrEP could
be an effective HIV prevention tool for FSWs, but is unlikely to
achieve the same population level impact as existing condom
use promotion interventions among FSWs (Pickles et al., 2013;
Williams et al., 2014). This highlights these interventions should
remain the mainstay HIV prevention strategy for FSWs (Alary et al.,
2013), with PrEP only being implemented once condom promotion
interventions have been maximised or to ﬁll prevention gaps where
high condom use cannot be achieved. This could include scenarios
where other male sexual partners play an important role in HIV
transmission but are reluctant to use condoms. An improved under-
standing of the role of these men  in HIV transmission amongst FSWs
is needed before recommendations can be made about scaling up
PrEP in such settings.
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